Kane A D, Ndiaye M B, Pessinaba S, Mbaye A, Bodian M, Driouch M E, Jobe M, Diao M, Sarr M, Kane A, Ba S A
Cardiology Department, Aristide Le Dantec Teaching Hospital, Dakar, Senegal.
Cardiovasc J Afr. 2012 Nov 23;23(10):e1-4. doi: 10.5830/CVJA-2012-035.
Permanent cardiac pacing is a technique whose indications have increased in the last 20 years. As with any foreign body, pacemaker implantation is associated with the risk of infection. The objective of this study was to describe the clinical, paraclinical and treatment options of infections secondary to pacemaker implantation at the Cardiology Department of the Aristide le Dantec Teaching Hospital (CHU Aristide le Dantec) in Dakar, Senegal.
We conducted a retrospective study over a period of three years (from January 2005 to December 2007) during which pacemaker implantation was carried out in 107 patients. All patients with local and/or systemic signs of infection were included in our study.
The prevalence of infection in patients with pacemakers was 5.6% in our series and infection occurred in three women and three men, with a mean age of 66.2 years (range 23-83). The delay time for the onset of clinical signs of infection was 6.6 months, with a range of eight days to 12 months. The clinical signs were externalisation of the pacemaker with suppuration (five cases), fever (one case) and inflammatory signs (one case). Factors favouring the occurrence of infection were co-morbidity (four cases), pre-operative length of stay (average eight days), use of temporary cardiac pacing (three cases), the number of people in the theatre (average 4.5), postoperative haematoma (one case) and repeating the surgical procedure (three cases). Staphylococcus epidermidis (two cases), Staphylococcus aureus (two cases) and Klebsiella pneumonia (one case) were the organisms isolated at the local site. Transthoracic echocardiography showed no objective signs of endocarditis. The treatment was antibiotic therapy for an average duration of 50.4 days after debridement of the infected site (six cases). We noted four recurrences at six months and one death from sepsis at 12 months.
Infections secondary to pacemaker implantation are rare but serious. Their management is difficult and requires the removal of the implanted material, hence the importance of prevention of infection, or the removal and re-implantation of the pacemaker at another site in cases of infection. This is particularly important in our region where pacemakers are very expensive.
永久性心脏起搏是一项在过去20年中适应证不断增加的技术。与任何异物一样,起搏器植入与感染风险相关。本研究的目的是描述塞内加尔达喀尔阿里斯蒂德·勒丹泰克教学医院(CHU Aristide le Dantec)心内科起搏器植入后继发感染的临床、辅助检查及治疗选择。
我们进行了一项为期三年(从2005年1月至2007年12月)的回顾性研究,在此期间107例患者接受了起搏器植入。所有有局部和/或全身感染迹象的患者均纳入本研究。
在我们的系列研究中,起搏器植入患者的感染患病率为5.6%,感染发生在3名女性和3名男性中,平均年龄为66.2岁(范围23 - 83岁)。感染临床症状出现的延迟时间为6.6个月,范围为8天至12个月。临床症状包括起搏器外露伴化脓(5例)、发热(1例)和炎症体征(1例)。有利于感染发生的因素包括合并症(4例)、术前住院时间(平均8天)、使用临时心脏起搏(3例)、手术室人数(平均4.5人)、术后血肿(1例)和重复手术操作(3例)。在局部部位分离出的病原体有表皮葡萄球菌(2例)、金黄色葡萄球菌(2例)和肺炎克雷伯菌(1例)。经胸超声心动图未显示心内膜炎的客观体征。治疗方法为在感染部位清创后平均持续50.4天的抗生素治疗(6例)。我们注意到6个月时有4例复发,12个月时有1例因败血症死亡。
起搏器植入后继发感染虽罕见但严重。其处理困难,需要移除植入材料,因此预防感染很重要,或者在感染情况下在另一部位移除并重新植入起搏器。这在我们这个起搏器非常昂贵的地区尤为重要。